ArticlePharmaceutics2020

Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil

Takuma Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.